Favorable fatty acid composition in adipose tissue in healthy Iraqi- compared to Swedish-born men - a pilot study using MRI assessment.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101567863 Publication Model: Print Cited Medium: Internet ISSN: 2162-397X (Electronic) Linking ISSN: 21623945 NLM ISO Abbreviation: Adipocyte Subsets: MEDLINE
    • Publication Information:
      Publication: 2015- : Philadelphia, PA : Taylor & Francis
      Original Publication: Austin, TX : Landes Bioscience
    • Subject Terms:
    • Abstract:
      Middle Eastern immigrants are at high-risk for insulin resistance. Fatty acid composition (FAC) plays an important role in the development of insulin resistance but has not been investigated in people of Middle Eastern ancestry. Here, the aim was to assess the FAC in visceral and subcutaneous adipose tissue (VAT and SAT) in healthy Iraqi- and Swedish-born men using a magnetic resonance imaging (MRI) method.This case-control study included 23 Iraqi- and 15 Swedish-born middle-aged men, without cardiometabolic disease. Using multi-echo MRI of the abdomen, the fractions of saturated, monounsaturated, and polyunsaturated fatty acids (fSFA, fMUFA, and fPUFA) were estimated in VAT and SAT. SAT was further analyzed in deep and superficial compartments (dSAT and sSAT).In all depots, fPUFA was significantly higher and fSFA significantly lower in Iraqi men, independently of age and BMI. In both Iraqi- and Swedish-born men, higher fPUFA and lower fMUFA were found in sSAT vs. dSAT. Among Iraqi men only, higher fPUFA and lower fMUFA were found in SAT vs. VAT.Iraqi-born men presented a more favorable abdominal FAC compared to Swedish-born men. This MRI method also revealed different FACs in different abdominal depots. Our results may reflect a beneficial FAC in Middle Eastern immigrants.
    • References:
      Atherosclerosis. 2001 Dec;159(2):441-9. (PMID: 11730825)
      Magn Reson Imaging. 2011 Oct;29(8):1041-6. (PMID: 21868182)
      Prog Lipid Res. 2008 Sep;47(5):348-80. (PMID: 18435934)
      J Magn Reson Imaging. 2019 Jun;49(6):1587-1599. (PMID: 30328237)
      Magn Reson Med. 2012 Dec;68(6):1815-27. (PMID: 22334300)
      J Lipid Res. 2008 Sep;49(9):2055-62. (PMID: 18509197)
      Int J Food Sci Nutr. 2018 Dec;69(8):916-927. (PMID: 29616827)
      Am J Clin Nutr. 2001 Nov;74(5):585-91. (PMID: 11684525)
      Int J Obes (Lond). 2017 Aug;41(8):1295-1298. (PMID: 28465608)
      NMR Biomed. 2014 Oct;27(10):1211-21. (PMID: 25125224)
      J Am Coll Cardiol. 2016 Jul 5;68(1):53-63. (PMID: 27364051)
      Magn Reson Med. 2020 Nov;84(5):2484-2494. (PMID: 32378739)
      Nutr J. 2012 Dec 14;11:109. (PMID: 23237668)
      Acta Diabetol. 2020 May;57(5):597-603. (PMID: 31863321)
      J Magn Reson Imaging. 2007 Oct;26(4):1153-61. (PMID: 17896369)
      Ann Nutr Metab. 2011;59(2-4):176-86. (PMID: 22142965)
      Diabetes Care. 2014;37(3):821-9. (PMID: 24186879)
      Nutrients. 2018 Mar 22;10(4):. (PMID: 29565831)
      NMR Biomed. 2017 Oct;30(10):. (PMID: 28678410)
      Chem Phys Lipids. 2008 Feb;151(2):103-9. (PMID: 18060873)
      Clin Chem. 1972 Jun;18(6):499-502. (PMID: 4337382)
      Diabetol Metab Syndr. 2016 Feb 12;8:10. (PMID: 26877772)
      Diabetes Res Clin Pract. 2014 Jul;105(1):79-87. (PMID: 24842242)
      Sci Rep. 2017 Mar 07;7:43521. (PMID: 28266592)
      Int J Obes (Lond). 2013 Apr;37(4):620-2. (PMID: 22641063)
      Obes Rev. 2010 Jan;11(1):11-8. (PMID: 19656312)
      Am J Clin Nutr. 1980 Jan;33(1):81-5. (PMID: 7355785)
      NMR Biomed. 2010 Jun;23(5):466-72. (PMID: 20099371)
      Magn Reson Imaging. 2018 Nov;53:148-155. (PMID: 30006022)
      Clin Chem. 1974 Apr;20(4):470-5. (PMID: 4818200)
      Diabetologia. 2021 Jan;64(1):95-108. (PMID: 32979073)
      Magn Reson Med. 2013 Mar 1;69(3):688-97. (PMID: 22532403)
      Healthcare (Basel). 2017 Jun 21;5(2):. (PMID: 28635680)
      J Lipid Res. 1997 Oct;38(10):2012-22. (PMID: 9374124)
      Am J Med. 2015 Mar;128(3):229-38. (PMID: 25447615)
      Curr Diabetes Rev. 2010 Mar;6(2):126-33. (PMID: 20201798)
      Lancet. 2004 Sep 11-17;364(9438):937-52. (PMID: 15364185)
      Prim Care Diabetes. 2014 Oct;8(3):231-8. (PMID: 24472421)
      Nutrients. 2018 Oct 15;10(10):. (PMID: 30326589)
      Curr Hypertens Rep. 2013 Dec;15(6):694-702. (PMID: 24091874)
      N Engl J Med. 2014 Dec 4;371(23):2237-8. (PMID: 25470706)
      Clin Chem. 1986 Mar;32(3):526-9. (PMID: 3948400)
      J Hypertens. 2014 Dec;32(12):2362-70; discussion 2370. (PMID: 25255394)
      NMR Biomed. 2017 Sep;30(9):. (PMID: 28543814)
      NMR Biomed. 2011 Aug;24(7):784-90. (PMID: 21834002)
      J Lipid Res. 2008 Feb;49(2):473-80. (PMID: 18024705)
    • Contributed Indexing:
      Keywords: Adipose tissue composition; MRI; cardiometabolic disease; migration; water-fat imaging
    • Accession Number:
      0 (Fatty Acids)
    • Publication Date:
      Date Created: 20220316 Date Completed: 20220504 Latest Revision: 20220504
    • Publication Date:
      20240829
    • Accession Number:
      PMC8928862
    • Accession Number:
      10.1080/21623945.2022.2042963
    • Accession Number:
      35291924